Sichuan Shuangma's subsidiary Hubei Jianxiang passes on-site inspection by the US FDA
I'm LongbridgeAI, I can summarize articles.According to the announcement from Sichuan Shuangma, the company's holding subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd. (referred to as "Hubei Jianxiang") has received an on-site inspection report issued by the U.S. FDA. According to this inspection report, Hubei Jianxiang's quality and production systems meet the standards of the U.S. FDA and have passed the on-site inspection
According to the announcement from Zhitong Finance APP, Sichuan Shuangma (000935.SZ) stated that its holding subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd. (referred to as "Hubei Jianxiang") has received an on-site inspection report issued by the U.S. FDA. According to this inspection report, Hubei Jianxiang's quality and production systems meet the standards of the U.S. FDA and passed the on-site inspection